Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: A potential mechanism of insulin sensitization

Endocrinology

Volumn 143, Issue 3, 2002, Pages 998-1007

  Combs, Terry P ^a   Wagner, John A ^b   Berger, Joel ^b   Doebber, Tom ^b   Wang, Wen Jun ^a   Zhang, Bei B ^b   Tanen, Michael ^b   Berg, Anders H ^a   O'Rahilly, Stephen ^c   Savage, David B ^c   Chatterjee, Krishna ^c   Weiss, Stuart ^d   Larson, Patrick J ^b   Gottesdiener, Keith M ^b   Gertz, Barry J ^b   Charron, Maureen J ^a   Scherer, Philipp E ^a   Moller, David E ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d San Diego Endocrine and Medical Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PLACEBO; ROSIGLITAZONE; STREPTOZOCIN;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOUSE; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL;

EID: 4243645912     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.3.8662     Document Type: Article

References (37)

1. The effect of CP 68,722, a thiazolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats
2. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice
3. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats
4. Repeat treatment of obese mice with BRL 49653, a new and potent insulin sensitizer, enhances insulin action in white adipocytes
5. Effect of pioglitazone (AD-4833) on insulin stimulated glucose disposal in NIDDM, an assessment by the euglycemic hyperinsulinemic clamp method
6. Metabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjects
7. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
8. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ
9. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones
10. Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects
11. Non thiazolidinedione antihyperglycaemic agents. 1: A-heteroatom substituted b-phenylpropanoic acids
12. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus, and hypertension
13. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat
14. Role of skeletal muscle in thiazolidinedione insulin sensitizer action
15. An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissue
16. Regulation of PPARγ gene expression by nutrition and obesity
17. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target
18. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
19. A novel serum protein similar to C1q, produced exclusively in adipocytes
20. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
21. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
22. Insulin-dependent phosphorylation of the insulin receptor-protein kinase and activation of glucose transport in 3T3-L1 adipocytes
23. Nongenetic mouse models of non-insulin-dependent diabetes mellitus
24. Confidence intervals for between-treatment mean difference when analysis is on the log percent of baseline scale
25. Indole acetic acids as novel PPARγ agonists
26. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
27. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
28. AdipoQ is a novel adipose-specific gene dysregulated in obesity
29. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor
30. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2
31. Chromosomal localization, expression pattern and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30
32. Troglitazone increases the number of small adipocytes without the changes of white adipose tissue mass in obese Zucker rats
33. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4
34. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptor and L6 myotubes
35. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
36. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
37. The PPARs: From orphan receptors to drug discovery